RHYTHM PHARMACEUTICALS, INC. 4

CTO Joseph Shulman exercised options and sold 5,079 Rhythm Pharmaceuticals (RYTM) shares as part of a larger option exercise, increasing his direct holdings to 20,994 shares.

On August 13, 2026, Rhythm Pharmaceuticals Chief Technical Officer Joseph Shulman exercised stock options for 20,244 shares of common stock at an exercise price of $6.80 per share (a routine, previously granted compensation award) and immediately sold 5,079 of the resulting shares at $119.75 per share under a Rule 10b5-1 trading plan, generating proceeds of approximately $607,000 while retaining a materially increased direct ownership stake of 20,994 shares post-transaction.

Filing Facts

CIK

1649904

Ticker

RYTM

Form

4

Source Type

fda

Accession

0001649904-26-000015

Alert Tier

5